41P: Network meta-analysis (NMA) of the first-line therapy for advanced non-squamous non-small cell lung cancer (nsNSCLC): Does PD-L1 expression modify effect of the immunotherapy on the overall survival (OS)?

Category Systematic review
JournalJ. Thorac. Oncol.
Year 2025
This article has no abstract
Epistemonikos ID: 1053919e5826ea2132d97a79cb8bb0848e6dc39b
First added on: Mar 25, 2025